Increased renal production of transforming growth factor-β1 in patients with type II diabetes

Diabetes

Volumn 46, Issue 5, 1997, Pages 854-859

  Sharma, Kumar ^a,d   Ziyadeh, Fuad N ^b   Alzahabi, Bashar ^a   McGowan, Tracy A ^a   Kapoor, Shiv ^b   Kurnik, Brenda R C ^c   Kurnik, Peter B ^c   Weisberg, Lawrence S ^c  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Department of Surgery   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIABETIC NEPHROPATHY; FEMALE; HUMAN; KIDNEY BLOOD FLOW; MALE; MESANGIUM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL;

EID: 0030975614     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.46.5.854     Document Type: Article

References (48)

1. Osterby R, Gundersen HJG: Glomerular size and structure in diabetes mellitus: late abnormalities. Diabetologia 11:225-229, 1975
2. Mauer SM, Steffes MW, Ellis EN, Sutherland DER, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1155, 1984
3. Ziyadeh FN, Goldfarb S: The renal tubulointerstitium in diabetes mellitus. Kidney Int 39:464-475, 1991
4. The Diabetes Control and Complications Trial Research Group: The effects of intensive insulin treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. Castilla A, Prieto J, Fausto N: Transforming growth factors β1 and a in chronic liver disease. N Engl J Med 324:933-940, 1991
6. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE, Nguyen HV, Aiello LM, Ferrara N, King GL: Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480-1487, 1994
7. Hussain M, Peakman M, Leslie R, Viberti G, Watkins P, Vergani D: Circulating levels of interleukin-1α (IL-1α), tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) are high in newly-diagnosed type I diabetes. Kidney Int 43:585-591, 1993
8. Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL: Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328:1592-1598, 1993
9. Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K: Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 327:1774-1778, 1992
10. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: the case for transforming growth factor-β as a key mediator. Diabetes 44:1139-1146, 1995
11. Rocco M, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 41:107-114, 1992
12. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:647-656, 1992
13. Bollineni JS, Reddi AS: Transforming growth factor-β1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 42:1673-1677, 1993
14. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
15. Sharma K, Ziyadeh FN: Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol 267:F1094-F1101, 1994
16. Yang C-W, Hattori M, Vlassara H, He C-J, Carome MA, Yamato E, Elliot S, Striker G, Striker LJ: Overexpression of transforming growth factor-β1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Neph 5:1610-1617, 1995
17. Yamamoto T, Nakamura T, Noble NA Ruoslahti E, Border WA: Expression of transforming growth factor beta is elevated in human and experimental dia­ betic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1993
18. Nakamura T, Fukui M, Ebihara I, Osada S, Nagaoka I, Tomino Y, Koide H: mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
19. Shankland SJ, Scholey JW: Expression of transforming growth factor-β1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
20. Fukui M, Nakamura T, Ebihara I, Osada S, Tomino Y, Masaki T, Goto K, Furuichi Y, Koide H: Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 122:149-156, 1993
21. Nakamura T, Ebihara I, Fukui M, Tomino Y, Koide H: Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli. Diabetes 44:895-899, 1995
22. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, Sporn MB: Type β transforming growth factor a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82:119-123, 1985
23. Roberts AB, McCune BK, Sporn MB: TGF-β: regulation of extracellular matrix. Kidney Int 41:557-559, 1992
24. Kon V, Badr KF: Biological actions and pathophysiologic significance of endothelin in the kidney. Kidney Int 40:1-12, 1991
25. Sharma K, Guo J, Jin Y, Ziyadeh FN: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
26. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A Gold LI, Border WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
27. Iwano M, Atsushi K, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fuji Y, Kanauchi M, Shiiki H, Dohi K: Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
28. Pfeiffer A Middleberg-Bisping K, Drewes C, Schatz H: Elevated plasma levels of transforming growth factor-β1 in NIDDM. Diabetes Care 19:1113-1117, 1996
29. Takahashi K, Ghatei MA, Lam H-C, O'Halloran DJ, Bloom SR: Elevated plasma endothelin in patients with diabetes mellitus. Diabetolagia 33:306-310, 1990
30. Lee Y-J, Shin S-J, Tsai J-H: Increased urinary endothelin-1-like immunoreactivity excretion in NIDDM patients with albuminuria. Diabetes Care 17:263-266, 1994
31. Cockgroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
32. Kurnik BRC, Weisberg LS, Kurnik PB: Renal and systemic oxygen consumption in patients with normal and abnormal renal function. J Am Soc Nephrol 2:1617-1626, 1992
33. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ, Rifkin DB: An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 216:276-284, 1994
34. Ohta K, Hirata Y, Shichuri M, Kanno K, Emori T, Tomita K, Marumo F: Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 39:307-311, 1991
35. Herman W, Hawthorne V, Hamman R, Keen H, De Fronzo R, Newman J, De Stefano F, Striker G, Hirschman G, Agodoa L: Consensus statement. Am J Kidney Dis 13:2-6, 1989
36. Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB: Recombinant latent transforming growth factor β1 has a longer halflife in rats than active transforming growth factor β1, and a different tissue distribution. J Clin Invest 86:1976-1984, 1990
37. Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, Grace AA, Schofleld PM, Chauhan A: The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nature Med 1:74-79, 1995
38. LaMarre J, Hayes MA, Wollenberg GK, Hussaini I, Hall SW, Gonias SL An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice. J Clin Invest 87:39-44, 1991
39. Wakefield LM, Letterio JJ, Chen T, Danielpour D, Allison RSH, Pai LH, Denicoff AM, Noone MH, Cowan KH, O'Shaughnessy JA, Sporn MB: Transforming growth factor-β1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1:129-136, 1995
40. Ignotz R, Endo T, Massague J: Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem 261:6443-6446, 1987
41. Sharma K, Ziyadeh FN: The emerging role of transforming growth factor-β in kidney diseases. Am J Physiol 35:F829-F842, 1994
42. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744, 1993
43. Isaka Y, Fuijiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomeruloscerosis induced by in vivo transfection of transforming growth factor-β or plateletderived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
44. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371-374, 1990
45. Cortes P, Riser BL, Zhao X, Narins RG: Glomerular volume expansion and mesangial cell mechanical strain: mediators of glomerular pressure injury. Kidney Int 45:S11-S16, 1994
46. Yang C-W, Vlassara H, Peten EP, He C-J, Striker GE, Striker LJ: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
47. Kagami S, Border WA, Miller DE, Noble NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
48. Wolf G, Mueller E, Stahl RAK, Ziyadeh FN: Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous TGF-β. J Clin Invest 92:1366-1373, 1993